반응식
[CH3:1][C@@H:2]([OH:5])[CH2:3][CH3:4].[H-].[Na+].Cl[C:9]1[C:10]([CH3:20])=[C:11]([CH3:19])[C:12]2[N:13]([C:15]([NH2:18])=[N:16][N:17]=2)[N:14]=1>CN(C=O)C>[C@H:2]([O:5][C:9]1[C:10]([CH3:20])=[C:11]([CH3:19])[C:12]2[N:13]([C:15]([NH2:18])=[N:16][N:17]=2)[N:14]=1)([CH2:3][CH3:4])[CH3:1]참가 물질
5
실험 절차
(R)-Butan-2-ol (0.5 ml) was deprotonated analogously to W1.056 with sodium hydride (85 mg) and reacted with 6-chloro-7,8-dimethyl-[1,2,4]triazolo[4,3-b]pyridazin-3-ylamine (W2.006a, 100 mg), suspended in DMF (2 ml), and worked up. 75 mg of the title compound were isolated in sufficient purity.
출처 및 근거
- ORD 기록
- ord-eec437a14e5a4a97b0c0659f93320104
- 출처 데이터셋
- uspto-grants-2011_12
- 특허 번호
- US08076336B2
연결된 노트
불러오는 중…